ClinicalTrials.gov Identifier: NCT02671500
ASIA: The study is evaluation Epclusa (one-pill, once-a-day) for a 12-week treatment duration in treatment naïve and treatment experienced people.
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
To read the entire clinical trial description, click here…
Share This Page